Skip to main content
. 2021 Jun 28;28(12):3357–3370. doi: 10.1038/s41418-021-00823-x

Fig. 8. LIN37 and RB contribute to MKI67 mRNA downregulation upon DNA damage induction and p53 activation.

Fig. 8

HCT116 wild-type (WT) and mutant cells were tested for mRNA expression of the MKI67 and the CDK inhibitor CDKN1A/p21 genes. Clonal cell lines for WT (n = 4), RB−/− (n = 3), LIN37−/− (n = 4), or double-knockout LIN37−/−; RB−/− (n = 2) cells were treated with nutlin-3a or doxorubicin for 48 h. As controls, untreated or DMSO (solvent control)-treated (48 h) cell lines were analyzed. Levels of mRNA from CDKN1A/p21 and MKI67 genes were determined by real-time RT-qPCR. The log2-fold changes in mRNA expression of treated vs. control cells are given. Mean values are indicated by black bars. Significances were calculated using the Student’s t-test (n.s., not significant; *p ≤ 0.05; **p ≤ 0.01; ***p ≤ 0.001).